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Abstract 
Introduction. The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a considerable 
threat to public health worldwide. The aim of this study was to determine the prevalence of CRKP isolated 
from clinical specimens by phenotypic and genotypic methods.
Methods. In total, 110 consecutive non-repetitive isolates of K. pneumoniae were analyzed. Minimal inhi-
bitory concentrations (MICs) of imipenem were determined. The mechanism of resistance was evaluated 
by imipenem-EDTA combined disk test and modiﬁed Hodge test. PCR method was used for the detection of 
blaVIM, blaIMP, blaNDM-1, blaOXA-48 and KPC genes.
Results. Totally, 8 (7.3 %) isolates were resistant to imipenem, showing MIC ≥4 µg/mL. Based on imipenem-
EDTA combined disk test, all imipenem-resistant isolates were metallo-beta-lactamase (MBL) positive. 
PCR conﬁrmed that 6 (75%) isolates were blaNDM-1 positive. Other resistance genes (blaVIM, blaIMP, 
blaOXA-48 and KPC) were not detected.
Conclusions. Based on this study, the prevalence of CRKP strains was not at a high level, however, continuous 
monitoring of antibiotic resistance should be performed to control dissemination of CRKP infections. 
Introduction
Klebsiella pneumoniae (K. pneumoniae) 
is a Gram-negative, rod-shaped, encapsulated 
and non-motile bacterium that can cause 
different types of infections including 
upper respiratory tract infections (URTI), 
bloodstream infections, wound infections, 
meningitis and urinary tract infections (1). 
K. pneumoniae is one of the most important 
bacteria associated with health-care issues 
especially in patients with different risk 
factors including cancer, chronic liver disease, 
dialysis and previous antibiotic consumptions 
that make them more susceptible to K. 
pneumoniae infections (2, 3). 
Several investigations demonstrated 
that some isolates of K. pneumoniae are 
hypervirulent and are linked to severe 
diseases such as liver abscesses, lung 
abscesses, endophthalmitis and meningitis, 
with high rate of morbidity and mortality. 
The capsulated serotypes, a pathogenicity 
island and the virulence plasmids are the best 
known hypervirulence-associated factors 
in hypervirulent isolates of K. pneumoniae 
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(4, 5). 
Treatment of K. pneumoniae infections 
has become more complicated than before. 
A comprehensive report on infectious 
diseases in European countries published by 
the European Centre for Disease Prevention 
and Control (ECDC) revealed that the 
trend (2008-2011) of resistance against 
different antibiotics such as cephalosporin, 
carbapenem and aminoglycosides has 
significantly increased in the majority of 
European countries (6).
D i ff e r en t  an t ib io t i c  r e s i s t ance 
mechanisms, especially resistance to 
carbapenems, have been identified in K. 
pneumoniae. The production of beta-
lactamase enzymes is one of the most 
important mechanisms (7). According 
to Ambler classification, four types (A, 
B, C and D) of these enzymes have been 
identified. Based on molecular structure and 
protein homology these classes are divided 
into different subclasses. The most clinically 
important carbapenemase enzyme genes 
in carbapenem-resistant K. pneumoniae 
(CRKP) belong to Ambler class A (KPC 
type), class B (NDM, VIM and IMP types) 
and class D (OXA-48-like) (8). 
Given the substantial impact of CRKP 
on patients’ outcomes and the need of 
identifying resistance genes to curtail the 
spread of infection, the aim of this study was 
to determine the prevalence of CRKP isolates 
from clinical specimens by phenotypic and 
genotypic methods. 
Materials and methods
Specimen collection and identiﬁcation
In  to ta l ,  110  consecut ive  non-
repetitive isolates of K. pneumoniae were 
collected from patients referring to Sistan 
and Balouchestan hospitals. Standard 
biochemical tests including Gram-stain, 
catalase, and lactose fermentation were used 
for primary identification. Species-specific 
PCR was carried out using previously 
designed primers for ITS (16s–23s rRNA 
internal transcribed spacer) (9, 10). 
Antimicrobial susceptibility testing
Resistance to ertapenem (ETP, 10 µg), 
meropenem (MEM, 10 µg), ciprofloxacin 
(CIP, 5 µg), amikacin (AMK, 30 µg), 
gentamicin (GM, 10 µg), cefepime (CPM, 
30 µg), cefoxitin (FOX, 30 µg) and 
ceftriaxone (CRO, 30 µg) purchased from 
MSAT, Merseyside, UK, was evaluated by 
Kirby-Bauer’s disk diffusion method (11). 
Minimal inhibitory concentrations (MICs) 
of imipenem were determined according 
to CLSI guidelines and broth microdilution 
method (11). The concentration gradient 
for imipenem (Sigma-Aldrich, USA) was 
64-0.5 µg/mL. K. pneumoniae isolates that 
were resistant to imipenem were subjected 
to phenotypical detection of metallo-beta-
lactamase enzymes by imipenem-EDTA 
combined disk test as described earlier 
(12). The modified Hodge test (MHT) was 
performed based on CLSI recommendations. 
Briefly, standard suspension of E. coli 25922 
was prepared and inoculated into Muller-
Hinton agar. A 10 µg ertapenem disk (Mast, 
UK) was placed in the center of the plate. 
Suspected isolates were inoculated in straight 
line out from the edge of the disk. Finally, 
after an overnight incubation period, the 
presence of a “cloverleaf shaped” inhibition 
zone was considered positive (11). 
Molecular detection of resistance genes by 
polymerase chain reaction (PCR) 
Genomic DNAs were extracted by boiling 
method (13). Briefly, two fresh colonies of 
K. pneumoniae were suspended in 300 
µL sterile distilled water. After complete 
dissolving, the suspension was heated for 
10min at 100O C. Finally, after cooling 
at room temperature, the suspension was 
centrifuged at 13,000g for 10 min and the 
supernatant was used as a source of DNA 
template for amplification. PCR amplification 
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was carried out on extracted DNAs for the 
detection of blaVIM, blaIMP, blaNDM-1, 
blaOXA-48 and KPC genes using specific 
primers (14). All PCR amplifications were 
performed by using Ampliqon (Denmark) 
ready to use master mix. The following 
program was used: initial denaturation at 
94° C for 5 min, 30 cycles of denaturation 
at 94° C for 1 min, annealing at 51° C for 
1 min, extension at 72° C for 50 sec and a 
final extension at 72° C for 10 min. PCR 
products were separated by electrophoresis 
on 1% agarose gel and were stained with 
Sybr safe (Thermo Fisher Scientific Inc., 
USA). PCR products were sent to Macrogen 
(South Korea) company for purification and 
sequencing on both strands. We used Mega6 
as a multiple sequence alignment software 
and blast website (https://blast.ncbi.nlm.nih.
gov/Blast) for sequence analyzing (15).
Results
One hundred and ten isolates of K. 
pneumoniae were obtained from sputum 51 
(46.4%), urine 38 (34.5%), blood 12 (10.9%), 
wound 5 (4.5%) and other clinical specimens 
(trachea, synovial fluid and abscess) 4 (3.6%). 
From these, 49 (44.5%) were female and 61 
(55.5%) were male. Meanwhile, out of 110 
isolated bacteria 57 (51.8%) were from 
hospitalized patients and 53 (48.2%) were 
from outpatients. The highest susceptibility 
was observed against ertapenem (n = 102; 
92.7%) and meropenem (n = 102; 92.7%), 
followed by amikacin (n = 100; 90.9%), 
gentamicin (n = 97; 88.2%), cefepime (n = 
97; 88.2%), ciprofloxacin (n = 74; 67.3%), 
cefoxitin (69; 62.7%) and ceftriaxone (n = 
69; 62.7%). Totally, 8 (7.3%) isolates were 
resistant to imipenem, with MIC ≥4 µg/ml 
(Table 1). Other isolates showed MIC ≤1. 
Imipenem-resistant isolates were resistant 
to all antibiotics except to amikacin. Based 
on imipenem-EDTA combined disk test, 
all imipenem-resistant isolates were MBL 
positive. Meanwhile, modified Hodge 
test was positive in 2 imipenem-resistant 
isolates. PCR confirmed that 6 (75%) 
isolates contained blaNDM-1 (Figure 1). 
Other resistance genes (blaVIM, blaIMP, 
blaOXA48 and KPC) were not detected. 
Results of blast with other sequences 
deposited in GenBank database revealed 
99-100% similarity with blaNDM-1. 
Determined nucleotide sequences were 
submitted to GenBank under following 
accession numbers; MH102400, MH102401 
and MH120290. 
Table 1 - Characteristics of eight imipenem-resistant K. pneumoniae
Isolate ID Sex Source of isolation Hospitalization (ward) IPM MIC
(µg/ml)
MBL Resistance gene
A33 Female Sputum Yes (Emergency) 4 Positive bla-NDM-1
A35 Male Sputum Yes (Emergency) 64≤ Positive bla-NDM-1
A338 Female Urine Yes (ICU) 16 Positive bla-NDM-1
A387 Female Sputum No 16 Positive bla-NDM-1
A126 Female Sputum No 16 Positive bla-NDM-1
A134 Female Sputum Yes (Emergency) 16 Positive bla-NDM-1
A6 Male Wound Yes (ICU) 4 Positive Negative
A7 Female Urine No 4 Positive Negative
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Discussion
The use of antibiotics plays an important 
role in the treatment of infections caused by 
drug-susceptible microorganisms. However, 
the effectiveness of antibiotic therapy has 
been reduced owing to different mechanisms 
of antibiotic resistance. The emergence 
of drug-resistant infections is considered 
to be a serious challenge to human health 
worldwide. In fact, widespread use and 
misuse of antibiotics led to a decline in the 
effectiveness of traditional antimicrobial 
therapy and appropriate antibiotic selection 
(16). 
Carbapenems are among the main 
members of the beta-lactam antibiotics and 
are being used for treatment of infections 
caused by bacteria showing resistance against 
multiple antibiotics including penicillin 
and cephalosporins. Furthermore, studies 
revealed that CRKP infection is linked to 
high rate of mortality, morbidity, and health-
care costs (17). Therefore, determining the 
prevalence of CRKP isolates is completely 
necessary. 
Given the great impact of CRKP on 
patients’ outcomes and the availability of 
limited informations in our region, this study 
was conducted to evaluate the prevalence of 
CRKP in Sistan and Balouchestan province. 
Our findings revealed that the prevalence 
of CRKP was 7.3%. Results of different 
independent studies in Iran showed that the 
prevalence of CRKP is variable. For example, 
in a study from Tehran, Bina reported 
that 37% of investigated K. pneumoniae 
isolates were CR (18), while other studies 
conducted in Isfahan province demonstrated 
0% resistance against carbapenem (19, 20). 
Additionally, in comparison with European 
countries, our findings are much lower than 
Romania (24.7%), Italy (33.5%), and Greece 
(61.5%). However, reported prevalence is 
similar to Bulgaria (7.2%) and Malta (9.9%) 
(21). 
In this study, out of 8 carbapenem 
resistant isolates, 6 isolates were confirmed 
as MBL positive. On the other hand, in two 
isolates with positive imipenem-EDTA 
reaction, investigated MBL genes were 
not detected. This discrepancy might be 
Figure 1 - Agarose gel electrophoresis used for PCR product separation, lines 2, 7, and 14, 100bp ladder; lines 1, 4, 
6, 12, and 13 negative control; line 3, bla-VIM (390 bp) positive control; line 5, bla-IMP (232 bp) positive control; 
line 8, bla-NDM (621 bp) Positive control; lines 9, 10, and 11, clinical NDM positive isolates; lines 9, 10, 11, 15, 16, 
and 17, positive species-specific PCR (260 bp)
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related to other MBL genes or carbapenem 
resistance mechanisms such as Ambler 
class D beta-lactamases, mutation in outer 
membrane porins or efflux pump over-
expression. Additionally, it has been shown 
that bactericidal activity of EDTA may lead 
to false positive results once phenotypic 
methods are being applied (22, 23). 
Based on our results, blaNDM-1 gene 
is responsible for carbapenem resistance. 
For the first time, this gene was found in a 
K. pneumoniae isolated from urine culture 
of a male patient in Sweden who had been 
hospitalized in India (24). Following the 
first report of NDM in 2009, infections 
caused by NDM producer isolates have 
been reported from many other countries 
such as Vietnam, Netherlands, Serbia, 
Pakistan, Japan, Guatemala, Australia and 
the USA, indicating rapid and widespread 
dissemination (24). Since transferable 
plasmids harboring blaNDM often contain 
other antibiotic resistance genes, infection 
caused by NDM producer strains must be 
considered as a serious threat to patients’ 
health (25). 
This is the first report of blaNDM-1 
positive K. pneumoniae in Sistan and 
Balouchestan province. In Iran, blaNDM 
producer isolates have been previously 
reported from Isfahan and Tehran provinces. 
Shahcheraghi et al. during a study on 45 
clinical isolates of K. pneumoniae collected 
from Tehran hospitals, reported detection of 
blaNDM-1 (26). Likewise, Fazeli et al., in a 
study performed on 112 clinical isolates of 
K. pneumoniae collected from urine, sputum, 
wound, cerebrospinal fluid, bronchoalveolar-
lavage (BAL) and abscess between 2012 and 
2013, reported the presence of blaNDM-1 
among carbapenem-resistant isolates (27). 
Our results revealed that only two isolates 
of imipenem-resistant strains were MHT 
positive. This finding was in accordance 
with other reports. For instance, it has been 
shown that the overall sensitivity of MHT 
was low due to high rate of false negative 
results among blaNDM producer isolates 
(28, 29).
The detection of blaNDM harboring 
strains is of paramount importance because 
these isolates are often resistant against 
different antibiotics, resulting in limited 
available treatment options. Moreover, 
these resistance genes are often located at 
the transposable genetic elements such as 
plasmids and integrons; therefore, they can 
spread easily between bacteria by horizontal 
gene transfer (24, 25). 
Conclusions 
Infections caused by CRKP are considered 
to play a significant role in the treatment 
failure and poor patients’ outcomes. 
Therefore, continuous surveillance of the 
emergence of carbapenem-resistant isolates 
should be considered as a very important 
issue in the microbiology laboratories. In the 
present study, the prevalence of CRKP strains 
was not at a high level, however, constant 
monitoring of MBL-producing isolates is 
necessary in order to detect in real time the 
emergence of multi drug resistance (MDR) 
isolates and possibility of dissemination of 
resistance genes. Furthermore, phenotypic 
detection method by imipenem-EDTA was 
an accurate and simple method which can 
be used as a reliable detection method in all 
microbiology laboratories at any level. 
Although in this study the most important 
genes conferring resistance to carbapenems 
were investigated, in order to prevent the spread 
of resistant strains other resistance mechanisms 
including efflux pump over-expression, porin 
loss, and other beta-lactamase genes will also 
be studied in the future.
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Riassunto
Identificazione molecolare dei geni della carba-
penem-resistenza in ceppi di isolamento clinico di 
Klebsiella pneumoniae
Premessa. La comparsa di ceppi di Klebsiella pneu-
moniae carbapenem-resistenti costituisce un considere-
vole pericolo per la Sanità Pubblica a livello mondiale. 
Scopo del presente studio è di determinare con metodi 
fenotipici e genotipici la prevalenza in campioni clinici 
dei ceppi di K. pneumoniae carbapenem-resistenti. 
Metodi. In totale sono stati esaminati 110 isolamenti 
consecutivi non ripetitivci di K. pneumoniae, determi-
nandone le minime concentrazioni inibenti (MICs) di 
imipenem. Il meccanismo della resistenza è stato valutato 
con il test del disco combinato imipenem-EDTA e con 
il test di Hodge modificato. Il metodo PCR è stato usato 
per evidenziare i geni blaVIM, blaIMP, blaNDM-1, 
blaOXA-48 e KPC.
Risultati. Nell’insieme, 8 (7,3%) isolamenti sono 
risultati imipenem-resistenti, con un valore di MIC ≥4 µg/
mL. Sulla base del test del disco combinato imipenem-
EDTA, tutti gli isolamenti imipenem -resistenti sono 
risultati anche postivi alla metallo-beta-lattamasi (MBL). 
Il test PCR ha confermato che 6 (75%) degli isolamenti 
erano blaNDM-1 positivi. Non sono stati rinvenuti altri 
geni di resistenza (blaVIM, blaIMP, blaOXA-48 and 
KPC).
Conclusioni. Sulla base del presente studio la preva-
lenza dei ceppi CRKP non è risultata di frequenza ele-
vata, tuttavia un monitoraggio continuo della resistenza 
antibiotica deve essere mantenuta per controllare la 
disseminazione delle infezioni CRKP.
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